APO RESEARCH · REPORT
Artificial Blood Vessel
Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.
Product & engineering
Understand the product.
Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.
The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it’s a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g. collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better.
Selected research
Market Structure
Global Artificial Blood Vessel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Artificial blood vessels, also known as vascular prostheses, the main material of artificial blood vessel include: EPTFE, Polyethylene Terephthalate, Polyurethane and so on. The main function of artificial blood vessels can replace the pumping blood. Now mainly used for replacement of aorta, the role of artificial blood vessels are connected the two ends of blood vessels, the blood circulation to recover.
The current artificial blood vessels are mostly polyester fibers or PTFE fibers woven into the corrugation of the tube has certain porosity. It implanted in the body which can form a layer of fake endometrial. Due to avoiding coagulation and thrombosis, it’s a better solution to the problem of preventing thrombosis. An organism that can be absorbed by the material emerging non-absorbable material and cross-woven, or on the large pore fabric coating absorbable material (e.g. collagen fibers) of the artificial blood vessel, it is easy to fake endometrial growth acceleration effect better.
Asia-Pacific is the largest artificial blood vessel market with about 38% market share. North America is follower, accounting for about 30% market share.
Read the full market overview
The key players are Getinge, BD(Bard), Terumo etc. Top 1 company occupied about 45% market share.
This report provides an overview of the global Artificial Blood Vessel market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Artificial Blood Vessel and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Artificial Blood Vessel sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artificial Blood Vessel market size, projected growth trends, production technologies, key applications, and end-use industries.
Artificial Blood Vessel Segment by Company
Getinge
BD (Bard)
Terumo
W. L. Gore
Japan Lifeline
B.Braun
LeMaitre Vascular
Suokang
Chest Medical
Artificial Blood Vessel Segment by Type
EPTFE
Polyethylene Terephthalate
Polyurethane
Others
Artificial Blood Vessel Segment by Application
Aortic Disease
Peripheral Artery Disease
Hemodialysis
Artificial Blood Vessel Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Vessel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Vessel and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Vessel.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Artificial Blood Vessel market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Blood Vessel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Artificial Blood Vessel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Artificial Blood Vessel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- EPTFE
- Polyethylene Terephthalate
- Polyurethane
- Others
Applications
- Aortic Disease
- Peripheral Artery Disease
- Hemodialysis
Companies covered
- Getinge
- BD (Bard)
- Terumo
- W. L. Gore
- Japan Lifeline
- B.Braun
- LeMaitre Vascular
- Suokang
- Chest Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Artificial Blood Vessel Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Artificial Blood Vessel Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Artificial Blood Vessel Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Artificial Blood Vessel Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Artificial Blood Vessel Market Dynamics
- 2.1 Artificial Blood Vessel Industry Trends
- 2.2 Artificial Blood Vessel Industry Drivers
- 2.3 Artificial Blood Vessel Industry Opportunities and Challenges
- 2.4 Artificial Blood Vessel Industry Restraints
3 Artificial Blood Vessel Market by Manufacturers
- 3.1 Global Artificial Blood Vessel Revenue by Manufacturers (2021-2026)
- 3.2 Global Artificial Blood Vessel Sales by Manufacturers (2021-2026)
- 3.3 Global Artificial Blood Vessel Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Artificial Blood Vessel Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artificial Blood Vessel Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Artificial Blood Vessel Manufacturers, Product Type & Application
- 3.7 Global Artificial Blood Vessel Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Artificial Blood Vessel Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Artificial Blood Vessel Players Market Share by Revenue in 2025
- 3.8.3 2025 Artificial Blood Vessel Tier 1, Tier 2, and Tier 3
4 Artificial Blood Vessel Market by Type
- 4.1 Artificial Blood Vessel Type Introduction
- 4.1.1 EPTFE
- 4.1.2 Polyethylene Terephthalate
- 4.1.3 Polyurethane
- 4.1.4 Others
- 4.2 Global Artificial Blood Vessel Sales by Type
- 4.2.1 Global Artificial Blood Vessel Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Artificial Blood Vessel Sales by Type (2021-2032)
- 4.2.3 Global Artificial Blood Vessel Sales Market Share by Type (2021-2032)
- 4.3 Global Artificial Blood Vessel Revenue by Type
- 4.3.1 Global Artificial Blood Vessel Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Artificial Blood Vessel Revenue by Type (2021-2032)
- 4.3.3 Global Artificial Blood Vessel Revenue Market Share by Type (2021-2032)
5 Artificial Blood Vessel Market by Application
- 5.1 Artificial Blood Vessel Application Introduction
- 5.1.1 Aortic Disease
- 5.1.2 Peripheral Artery Disease
- 5.1.3 Hemodialysis
- 5.2 Global Artificial Blood Vessel Sales by Application
- 5.2.1 Global Artificial Blood Vessel Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Artificial Blood Vessel Sales by Application (2021-2032)
- 5.2.3 Global Artificial Blood Vessel Sales Market Share by Application (2021-2032)
- 5.3 Global Artificial Blood Vessel Revenue by Application
- 5.3.1 Global Artificial Blood Vessel Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Artificial Blood Vessel Revenue by Application (2021-2032)
- 5.3.3 Global Artificial Blood Vessel Revenue Market Share by Application (2021-2032)
6 Global Artificial Blood Vessel Sales by Region
- 6.1 Global Artificial Blood Vessel Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Artificial Blood Vessel Sales by Region (2021-2032)
- 6.2.1 Global Artificial Blood Vessel Sales by Region (2021-2026)
- 6.2.2 Global Artificial Blood Vessel Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Artificial Blood Vessel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Artificial Blood Vessel Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Artificial Blood Vessel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Artificial Blood Vessel Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Artificial Blood Vessel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Artificial Blood Vessel Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Artificial Blood Vessel Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Artificial Blood Vessel Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Artificial Blood Vessel Revenue by Region
- 7.1 Global Artificial Blood Vessel Revenue by Region
- 7.1.1 Global Artificial Blood Vessel Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Artificial Blood Vessel Revenue by Region (2021-2026)
- 7.1.3 Global Artificial Blood Vessel Revenue by Region (2027-2032)
- 7.1.4 Global Artificial Blood Vessel Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Artificial Blood Vessel Revenue (2021-2032)
- 7.2.2 North America Artificial Blood Vessel Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Artificial Blood Vessel Revenue (2021-2032)
- 7.3.2 Europe Artificial Blood Vessel Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Artificial Blood Vessel Revenue (2021-2032)
- 7.4.2 Asia-Pacific Artificial Blood Vessel Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Artificial Blood Vessel Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Artificial Blood Vessel Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Getinge
- 8.1.1 Getinge Company Information
- 8.1.2 Getinge Business Overview
- 8.1.3 Getinge Artificial Blood Vessel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Getinge Artificial Blood Vessel Product Portfolio
- 8.1.5 Getinge Recent Developments
- 8.2 BD (Bard)
- 8.2.1 BD (Bard) Company Information
- 8.2.2 BD (Bard) Business Overview
- 8.2.3 BD (Bard) Artificial Blood Vessel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 BD (Bard) Artificial Blood Vessel Product Portfolio
- 8.2.5 BD (Bard) Recent Developments
- 8.3 Terumo
- 8.3.1 Terumo Company Information
- 8.3.2 Terumo Business Overview
- 8.3.3 Terumo Artificial Blood Vessel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Terumo Artificial Blood Vessel Product Portfolio
- 8.3.5 Terumo Recent Developments
- 8.4 W. L. Gore
- 8.4.1 W. L. Gore Company Information
- 8.4.2 W. L. Gore Business Overview
- 8.4.3 W. L. Gore Artificial Blood Vessel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 W. L. Gore Artificial Blood Vessel Product Portfolio
- 8.4.5 W. L. Gore Recent Developments
- 8.5 Japan Lifeline
- 8.5.1 Japan Lifeline Company Information
- 8.5.2 Japan Lifeline Business Overview
- 8.5.3 Japan Lifeline Artificial Blood Vessel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Japan Lifeline Artificial Blood Vessel Product Portfolio
- 8.5.5 Japan Lifeline Recent Developments
- 8.6 B.Braun
- 8.6.1 B.Braun Company Information
- 8.6.2 B.Braun Business Overview
- 8.6.3 B.Braun Artificial Blood Vessel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 B.Braun Artificial Blood Vessel Product Portfolio
- 8.6.5 B.Braun Recent Developments
- 8.7 LeMaitre Vascular
- 8.7.1 LeMaitre Vascular Company Information
- 8.7.2 LeMaitre Vascular Business Overview
- 8.7.3 LeMaitre Vascular Artificial Blood Vessel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 LeMaitre Vascular Artificial Blood Vessel Product Portfolio
- 8.7.5 LeMaitre Vascular Recent Developments
- 8.8 Suokang
- 8.8.1 Suokang Company Information
- 8.8.2 Suokang Business Overview
- 8.8.3 Suokang Artificial Blood Vessel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Suokang Artificial Blood Vessel Product Portfolio
- 8.8.5 Suokang Recent Developments
- 8.9 Chest Medical
- 8.9.1 Chest Medical Company Information
- 8.9.2 Chest Medical Business Overview
- 8.9.3 Chest Medical Artificial Blood Vessel Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Chest Medical Artificial Blood Vessel Product Portfolio
- 8.9.5 Chest Medical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Artificial Blood Vessel Value Chain Analysis
- 9.1.1 Artificial Blood Vessel Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Artificial Blood Vessel Production Mode & Process
- 9.2 Artificial Blood Vessel Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Artificial Blood Vessel Distributors
- 9.2.3 Artificial Blood Vessel Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst